Research advances in antiviral drugs and their treatment regimens in chronic hepatitis C

VernacularTitle:慢性丙型肝炎抗病毒药物及其治疗方案研究进展
Author: Qun ZENG ¹ ; Shenghua JIE
Author Information

1. 华中科技大学同济医学院附属协和医院感染病科
Keywords: hepatitis C,chronic; antiviral agents; therapy; review
From: Journal of Clinical Hepatology 2017;33(11):2200-2204
CountryChina
Language:Chinese
Abstract: Chronic hepatitis C has become a serious public health issue around the world.In recent years,with the development of pharmacotherapy for hepatitis C,it may be possible to cure hepatitis C.With reference to the epidemic status of hepatitis C and the advantages and side effects of conventional standard therapy (pegylated interferon plus ribavirin) and various oral direct-acting antiviral agents (DAAs),this article summarizes the advantages and disadvantages of different combinations of DAAs in the treatment of chronic hepatitis C with different genotypes and briefly introduces the World Health Organization recommendations on the treatment of hepatitis C.Hepatitis C is expected to be eliminated with the development of pharmacotherapy for chronic hepatitis C.